RNA Market Cap & Key Metrics
Atrium Therapeutics, Inc.
$7.82
+$0.14(+1.82%)
20
Overall
--
Value
27
Tech
13
Quality
Market Cap
$131.37M
Volume
131.24K
52W Range
$7.63 - $16.77
Target Price
$25.00
RNA market cap is $131.37M. This page lists Atrium Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RNA Key Metrics
- Market cap
- $131.37M
- EPS estimate, current year
- $-5.08
- EPS growth, 3-year
- -32.37%
- Quality score
- 13
- Technical score
- 27
| Fiscal year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | $9.22M | $9.33M | $6.79M | $2.32M | $379.0K |
| EBITDA | -$172.61M | -$117.37M | -$43.77M | -$17.00M | -$10.12M |
| EPS | $-3.34 | $-2.85 | $-2.05 | $-1.44 | $-0.54 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNA | $7.82 | +1.8% | 131.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atrium Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW